A recent analysis reveals a modest decline from 2016 to 2020 in new and additional opioid prescriptions for patients with cancer. Among those patients with metastatic cancer, prescribing remained stable for those reporting any pain and declined steeply for those reporting no pain. The findings are published in the journal Cancer.
from Medical Xpress - latest medical and health news stories https://ift.tt/xs2huJY
